You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Bayer to acquire cell and gene therapy specialist AskBio

German pharma company Bayer has announced its acquisition of Asklepios BioPharmaceutical (AskBio), which specialises in the research, development and manufacturing of gene therapies.